We narrowed to 4,109 results for: yfp
-
Plasmid#224177PurposeAiE1026h is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal MSNs (DMS>DLS)DepositorInsertSYFP2-P2A-3XFLAG-10aa-H2B
UseAAVAvailable SinceSept. 26, 2024AvailabilityAcademic Institutions and Nonprofits only -
AiP14427 - pAAV-AiE1190m-minBG-SYFP2-P2A-3XFLAG-10aa-H2B-WPRE3-BGHpA (Alias: CN4427)
Plasmid#224181PurposeAiE1190m is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal D2 MSN>D1 MSNDepositorInsertSYFP2-P2A-3XFLAG-10aa-H2B
UseAAVAvailable SinceSept. 26, 2024AvailabilityAcademic Institutions and Nonprofits only -
AiP14425 - pAAV-AiE1180h-minBG-SYFP2-P2A-3XFLAG-10aa-H2B-WPRE3-BGHpA (Alias: CN4425)
Plasmid#224180PurposeAiE1180h is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal cholinergic neurons (weak)DepositorInsertSYFP2-P2A-3XFLAG-10aa-H2B
UseAAVAvailable SinceSept. 26, 2024AvailabilityAcademic Institutions and Nonprofits only -
AiP14428 - pAAV-AiE1191m-minBG-SYFP2-P2A-3XFLAG-10aa-H2B-WPRE3-BGHpA (Alias: CN4428)
Plasmid#224182PurposeAiE1191m is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal MSNsDepositorInsertSYFP2-P2A-3XFLAG-10aa-H2B
UseAAVAvailable SinceSept. 26, 2024AvailabilityAcademic Institutions and Nonprofits only -
AiP15049 - pAAV-AiE1425m-minBG-SYFP2-P2A-3XFLAG-10aa-H2B-WPRE3-BGHpA (Alias: CN5049)
Plasmid#224191PurposeAiE1425m is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal Sst_Chodl neuronsDepositorInsertSYFP2-P2A-3XFLAG-10aa-H2B
UseAAVAvailable SinceSept. 25, 2024AvailabilityAcademic Institutions and Nonprofits only -
AiP15045 - pAAV-AiE1421m-minBG-SYFP2-P2A-3XFLAG-10aa-H2B-WPRE3-BGHpA (Alias: CN5045)
Plasmid#224190PurposeAiE1421m is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal Pvalb+/Pthlh+ neuronsDepositorInsertSYFP2-P2A-3XFLAG-10aa-H2B
UseAAVAvailable SinceSept. 25, 2024AvailabilityAcademic Institutions and Nonprofits only -
AiP15042 - pAAV-AiE1418m-minBG-SYFP2-P2A-3XFLAG-10aa-H2B-WPRE3-BGHpA (Alias: CN5042)
Plasmid#224188PurposeAiE1418m is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal Pvalb+/Pthlh+ neuronsDepositorInsertSYFP2-P2A-3XFLAG-10aa-H2B
UseAAVAvailable SinceSept. 25, 2024AvailabilityAcademic Institutions and Nonprofits only -
AiP15041 - pAAV-AiE1417m-minBG-SYFP2-P2A-3XFLAG-10aa-H2B-WPRE3-BGHpA (Alias: CN5041)
Plasmid#224187PurposeAiE1417m is an enhancer sequence, designed to drive AAV-mediated transgene expression in striatal Pvalb+/Pthlh+ neuronsDepositorInsertSYFP2-P2A-3XFLAG-10aa-H2B
UseAAVAvailable SinceSept. 25, 2024AvailabilityAcademic Institutions and Nonprofits only -
pYUU
Plasmid#159751PurposeUbiquitin promoter-controlled expression of 3×FLAG-NLS-zCas9-NLS. Contains gRNA scaffold for insertion of target sequence (U6-26 promoter). Selection of transgenic seeds by YFP fluoresce.DepositorArticleInsertgRNA scaffold
UseCRISPRExpressionPlantAvailable SinceOct. 6, 2020AvailabilityAcademic Institutions and Nonprofits only -
pYEE
Plasmid#159750PurposeEgg cell-specific promoter-controlled expression of 3×FLAG-NLS-zCas9-NLS. Contains gRNA scaffold for insertion of target sequence (U6-26 promoter). Selection of transgenic seeds by YFP fluoresce.DepositorArticleInsertgRNA scaffold
UseCRISPRExpressionPlantAvailable SinceOct. 6, 2020AvailabilityAcademic Institutions and Nonprofits only -
pOTTC589 - pAAV c-fos Nuc-eYFP (AAV1)
Viral Prep#59133-AAV1PurposeReady-to-use AAV1 particles produced from pOTTC589 - pAAV c-fos Nuc-eYFP (#59133). In addition to the viral particles, you will also receive purified pOTTC589 - pAAV c-fos Nuc-eYFP plasmid DNA. C-fos-driven expression of Nuc-eYFP. These AAV preparations are suitable purity for injection into animals.DepositorPromotermFosAvailable SinceJan. 15, 2026AvailabilityAcademic Institutions and Nonprofits only -
pAAV-Ef1a-fDIO EYFP (AAV5)
Viral Prep#55641-AAV5PurposeReady-to-use AAV5 particles produced from pAAV-Ef1a-fDIO EYFP (#55641). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO EYFP plasmid DNA. EF1a-driven, Flp-dependent expression of EYFP. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aTagsEYFP (Flp-dependent)Available SinceOct. 21, 2024AvailabilityAcademic Institutions and Nonprofits only -
pAAV-CAG-DIO-EYFP (AAV PHP.V1)
Viral Prep#104052-AAVPHP.V1PurposeReady-to-use AAV PHP.V1 particles produced from pAAV-CAG-DIO-EYFP (#104052). In addition to the viral particles, you will also receive purified pAAV-CAG-DIO-EYFP plasmid DNA. CAG-driven, Cre-dependent expression of EYFP. These AAV were produced with the PHP.V1 serotype, which permits efficient transduction of brain vascular cells. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCAGTagsEYFP (Cre-dependent)Available SinceJuly 24, 2020AvailabilityAcademic Institutions and Nonprofits only -
pAAV-Ef1a-fDIO EYFP (AAV8)
Viral Prep#55641-AAV8PurposeReady-to-use AAV8 particles produced from pAAV-Ef1a-fDIO EYFP (#55641). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO EYFP plasmid DNA. EF1a-driven, Flp-dependent expression of EYFP. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aAvailable SinceDec. 18, 2024AvailabilityAcademic Institutions and Nonprofits only -
pAAV-Ef1a-fDIO EYFP (AAV2)
Viral Prep#55641-AAV2PurposeReady-to-use AAV2 particles produced from pAAV-Ef1a-fDIO EYFP (#55641). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO EYFP plasmid DNA. EF1a-driven, Flp-dependent expression of EYFP. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aTagsEYFP (Flp-dependent)Available SinceSept. 27, 2023AvailabilityAcademic Institutions and Nonprofits only -
pAAV-S5E2-C1V1-eYFP (AAV9)
Viral Prep#135633-AAV9PurposeReady-to-use AAV9 particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.DepositorTagsEYFPAvailable SinceAug. 27, 2021AvailabilityAcademic Institutions and Nonprofits only -
pAAV-nEF-Con/Foff 2.0-Arch3.3-EYFP (AAV8)
Viral Prep#137149-AAV8PurposeReady-to-use AAV8 particles produced from pAAV-nEF-Con/Foff 2.0-Arch3.3-EYFP (#137149). In addition to the viral particles, you will also receive purified pAAV-nEF-Con/Foff 2.0-Arch3.3-EYFP plasmid DNA. nEF-driven, Cre-dependent expression of Arch3.3-EYFP (inhibited in presence of Flp) for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.DepositorPromoternEFTagsEYFP (Cre-dependent)Available SinceMay 6, 2021AvailabilityAcademic Institutions and Nonprofits only -
pAAV-TRE-DIO-eYFP (AAV1)
Viral Prep#117383-AAV1PurposeReady-to-use AAV1 particles produced from pAAV-TRE-DIO-eYFP (#117383). In addition to the viral particles, you will also receive purified pAAV-TRE-DIO-eYFP plasmid DNA. Tet-inducible, Cre-dependent eYFP expression. These AAV preparations are suitable purity for injection into animals.DepositorPromoterTRETagseYFP (Tet-inducible, Cre-dependent)Available SinceJan. 6, 2022AvailabilityAcademic Institutions and Nonprofits only -
pAAV-S5E2-C1V1-eYFP (AAV PHP.eB)
Viral Prep#135633-PHPeBPurposeReady-to-use AAV PHP.eB particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorTagsEYFPAvailable SinceAug. 27, 2021AvailabilityAcademic Institutions and Nonprofits only -
pAAV-hSyn-eNpHR 3.0-EYFP (AAV2)
Viral Prep#26972-AAV2PurposeReady-to-use AAV2 particles produced from pAAV-hSyn-eNpHR 3.0-EYFP (#26972). In addition to the viral particles, you will also receive purified pAAV-hSyn-eNpHR 3.0-EYFP plasmid DNA. hSyn-driven eNpHR 3.0-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynAvailable SinceAug. 7, 2025AvailabilityAcademic Institutions and Nonprofits only